S2Medical AB (publ) (STO:S2M)
Sweden · Delayed Price · Currency is SEK 0.0146
+0.0006 (4.29%)
Jul 16, 2025, 4:30 PM CET
S2Medical AB Revenue
In the year 2024, S2Medical AB had annual revenue of 14.68M SEK with 90.03% growth. S2Medical AB had revenue of 3.83M in the quarter ending December 31, 2024, with 44.07% growth.
Revenue
14.68M
Revenue Growth
+90.03%
P/S Ratio
0.84
Revenue / Employee
2.10M
Employees
7
Market Cap
12.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.68M | 6.95M | 90.03% |
| Dec 31, 2023 | 7.72M | 1.56M | 25.39% |
| Dec 31, 2022 | 6.16M | -4.47M | -42.08% |
| Dec 31, 2021 | 10.63M | -17.33M | -61.98% |
| Dec 31, 2020 | 27.97M | 22.37M | 399.50% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.31B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Camurus AB | 2.04B |
| Medicover AB | 23.56B |
| Vimian Group AB | 4.24B |
| AddLife AB | 10.42B |